New BlockhouseCH House will seek to Coordinate Top Creators and Experts to Drive Value in Emerging Tokenized Digital Content MarketplaceLOS...
Loughborough, England, April 21, 2021 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (NASDAQ: NMRD) (“Nemaura” or the “Company”), a medical technology...
Primary efficacy in the second interim analysis demonstrates COVAXIN to be 78% effective after the second dose in preventing COVID-19...
MONTREAL, April 21, 2021 (GLOBE NEWSWIRE) -- ExCellThera Inc., a clinical-stage cell and molecular medicine company delivering molecules and bioengineering...
Summit Therapeutics Inc.(‘Summit’ or the ‘Company’) Summit Therapeutics Announces Commencement of Rights Offering Cambridge, MA, April 21, 2021 - Summit...
CARLSBAD, Calif., April 21, 2021 (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on...
Over 5000 Patients Enrolled in 20 countriesEDMONTON, Alberta, April 21, 2021 (GLOBE NEWSWIRE) -- Translational Research In Oncology (TRIO) today...
VANCOUVER, British Columbia, April 21, 2021 (GLOBE NEWSWIRE) -- “AI has no greater purpose than improving the health of everyone,”...
TORONTO, April 21, 2021 (GLOBE NEWSWIRE) -- New Leaf Canada Inc. today announced it has received approval from Health Canada...
Company’s specimen collection kit now available for use in COVID-19 testing in the U.S. Sample collection kit can be used...
Adverum Slate Background Adverum Slate Background Adverum Board Matrix Adverum Board Matrix Sonic’s Nominees Lack Experience and Qualifications to Advance...
REHOVOT, Israel and WILMINGTON, Del., April 21, 2021 (GLOBE NEWSWIRE) -- Ayala Pharmaceuticals, Inc. (Nasdaq: AYLA), a clinical-stage oncology company...
AUSTIN, Texas, April 21, 2021 (GLOBE NEWSWIRE) -- SmallCapVoice.com Inc. (“SCV”) announces the availability of a new interview with Bill...
CLASSICAL-Lung study evaluated pepinemab in combination with the checkpoint inhibitor BAVENCIO® for the treatment of non-small cell lung cancerROCHESTER, N.Y.,...
New combination trial of an RNA-targeted therapeutic candidate and an HBV immunotherapeutic candidate aimed at delivering a functional cure for...
Company on track to initiate prophylactic study of PHVS416ZUG, Switzerland, April 21, 2021 (GLOBE NEWSWIRE) -- Pharvaris (Nasdaq: PHVS), a...
Five-year outcomes demonstrate HAV retained durability and structural integrity, potentially offering a safe and viable option for long-term hemodialysisLong-term explant...
WORCESTER, Mass., April 21, 2021 (GLOBE NEWSWIRE) -- Mustang Bio, Inc. (“Mustang”) (NASDAQ: MBIO), a clinical-stage biopharmaceutical company focused on...
WOBURN, Mass., April 21, 2021 (GLOBE NEWSWIRE) -- Replimune Group, Inc. (Nasdaq: REPL), a biotechnology company developing oncolytic immuno-gene therapies...
Cannabis industry leader to hold conference call on May 5SALINAS, Calif., April 21, 2021 (GLOBE NEWSWIRE) -- Lowell Farms (CSE:LOWL;...